-
Afamelanotide, sold
under the
brand name Scenesse, is a
medication used to
prevent phototoxicity and to
reduce pain from
light exposure for
people with...
- lobe of the
pituitary gland.
Synthetic analogues of α-MSH, such as
afamelanotide (melanotan I; Scenesse),
melanotan II, and
bremelanotide (PT-141), have...
-
nausea and vomiting. As a
tanning agent,
melanotan I (now
known as
afamelanotide) was
licensed by
Competitive Technologies, a
technology transfer company...
-
effects against ultraviolet (UV)
radiation from the sun. They
include afamelanotide (melanotan) and
melanotan II, the
former of
which has been approved...
- and
racist antics in
nearly every episode. As of July 2013[update],
afamelanotide is in
phase II and III
clinical trials for
vitiligo and
other skin diseases...
-
Retrieved 2020-09-24. "Scenesse (
afamelanotide) for
adults with a
history of
phototoxic reactions from EPP". SCENESSE® (
Afamelanotide).
Retrieved 2020-09-24. Kraemer...
-
other peptide analogues of the same
family as
bremelanotide include afamelanotide (NDP-α-MSH), modimelanotide, and setmelanotide.
Studies in the early...
-
peptide and agouti-related peptide, and
activated by
synthetic (i.e.
afamelanotide) and
endogenous agonist melanocyte-stimulating hormones.
Several selective...
-
Melanocortin receptor modulators MC1 Agonists: ACTH (corticotropin)
Afamelanotide (melanotan I) BMS-470539
Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan...
-
approved for
chronic weight management in
patients with
genetic obesity.
Afamelanotide (Scenesse) is an MC1R
agonist approved for
patients with erythropoietic...
